| First Author | Mizoguchi A | Year | 2016 |
| Journal | J Pathol | Volume | 238 |
| Issue | 2 | Pages | 205-19 |
| PubMed ID | 26387641 | Mgi Jnum | J:227714 |
| Mgi Id | MGI:5702521 | Doi | 10.1002/path.4640 |
| Citation | Mizoguchi A, et al. (2016) Genetically engineered mouse models for studying inflammatory bowel disease. J Pathol 238(2):205-19 |
| abstractText | Inflammatory bowel disease (IBD) is a chronic intestinal inflammatory condition that is mediated by very complex mechanisms controlled by genetic, immune, and environmental factors. More than 74 kinds of genetically engineered mouse strains have been established since 1993 for studying IBD. Although mouse models cannot fully reflect human IBD, they have provided significant contributions for not only understanding the mechanism, but also developing new therapeutic means for IBD. Indeed, 20 kinds of genetically engineered mouse models carry the susceptibility genes identified in human IBD, and the functions of some other IBD susceptibility genes have also been dissected out using mouse models. Cutting-edge technologies such as cell-specific and inducible knockout systems, which were recently employed to mouse IBD models, have further enhanced the ability of investigators to provide important and unexpected rationales for developing new therapeutic strategies for IBD. In this review article, we briefly introduce 74 kinds of genetically engineered mouse models that spontaneously develop intestinal inflammation. Copyright (c) 2015 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. |
